Prof. Dr. BÜLENT ÜNDAR

Yayın Ağı

Makaleler 59

1. Clinical Outcomes and Treatment Patterns of Primary Central Nervous System Lymphoma: Multicenter Retrospective Analysis

GÜVEN S., YAVUZ B., Yucel E. E., KARATAŞ A. F., ÖZSAN G. H., DEMİRKAN F., et al.

Eurasian Journal of Medicine and Oncology , cilt.7, sa.1, ss.49-56, 2023 (Scopus)

2. quality of life, sexual satisfaction, anxiety and depression status in lymphoma survivors

Solmaz S., Çetintepe T., Türkyılmaz D., Aşık N., Demirkan F., Özcan M. A., et al.

international journal of sexual ahealthnd reproductive health care , cilt.1, sa.5, ss.61-68, 2022 (Hakemli Dergi)

3. Prognostic Factors in Elderly Patients with Diffuse Large B-Cell Lymphoma and Their Treatment Results

ADIYAMAN S. C., ALACACIOĞLU İ., Danyeli A. E., Turkyilmaz D., Sevindik O. G., DEMİRKAN F., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.36, sa.2, ss.81-87, 2019 (SCI-Expanded)

4. Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?

Medeni S. S., Turkyilmaz D., Acar C., Sevindik O. G., YÜKSEL F., Piskin O., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.35, sa.4, ss.271-276, 2018 (SCI-Expanded)

5. Frontline nilotinib treatment in Turkish patients with Philadelphia chromosome-positive chronic Myeloid Leukemia in chronic phase: updated results with 2 years of follow-up

SAYDAM G., HAZNEDAROĞLU İ. C., KAYNAR L., Yavuz A., ALİ R., GÜVENÇ B., et al.

HEMATOLOGY , cilt.23, sa.10, ss.771-777, 2018 (SCI-Expanded)

6. A Comparison of Fresenius Com.Tec Cell and Spectra Optia Cell Separators for Autologous and Allogeneic Stem Cell Collections: Single Center Experience.

Solmaz S., Kahraman S., Sevindik O. G., Acar C., Turkyilmaz M., ALACACIOĞLU İ., et al.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion , cilt.34, sa.4, ss.677-683, 2018 (SCI-Expanded)

7. Is the platelet-to-lymphocyte ratio a new prognostic marker in multiple myeloma?

Solmaz S., Uzun Ö., Acar C., Sevindik O. G., Piskin O., Ozsan H. G., et al.

Journal of laboratory physicians , cilt.10, sa.4, ss.363-369, 2018 (ESCI)

8. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day+100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?

Medeni S. S., Acar C., Olgun A., Acar A., Seyhanli A., Taskiran E., et al.

CLINICAL TRANSPLANTATION , cilt.32, sa.9, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

9. Waldenström Makroglobulinemisi

Ündar B.

Türkiye Klinikleri , cilt.11, sa.2, ss.147-156, 2018 (Hakemli Dergi)

10. Demir Metabolizması

Ündar B.

HematoLog , sa.Temmuz 2017 Sayı 1, ss.9-23, 2017 (Hakemli Dergi)

11. Effects of bone marrow fibrosis and angiogenetic structure on autologous hematopoietic stem cell engraftment

Buyukkurt N., ÖZSAN G. H., Ozkal S., SEYDAOĞLU G., ALACACIOĞLU İ., ÖZCAN M. A., et al.

CUKUROVA MEDICAL JOURNAL , cilt.42, sa.3, ss.499-506, 2017 (ESCI)

12. Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase

SAYDAM G., HAZNEDAROĞLU İ. C., KAYNAR L., Yavuz A., ALİ R., GÜVENÇ B., et al.

EXPERT OPINION ON PHARMACOTHERAPY , cilt.17, sa.14, ss.1851-1858, 2016 (SCI-Expanded)

13. Tek merkez deneyimi; 156 hematolojik maligniteli hastanın 350 febril nötropeni atağı

KAHRAMAN S., ALP ÇAVUŞ S., TURGUT N., ÖZCAN M. A., YAPAR N., PİŞKİN Ö., et al.

Klinik Tıp Bilimleri Dergisi , cilt.4, sa.6, ss.24-30, 2016 (Hakemli Dergi)

14. Ex vivo evaluation of the effect of regulatory T cells on the anti-tumor activity of bortezomib in multiple myeloma

ERÇETİN A. P., ÖZCAN M. A., AKTAŞ S., YÜKSEL F., Solmaz S. M., Sevindik G. O., et al.

EXPERIMENTAL HEMATOLOGY , cilt.44, sa.4, ss.223-230, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

15. Akut Myeloid Lösemi Hastalarımızın Retrospektif Değerlendirilmesi

SOLMAZ Ş., SEVİNDİK Ö. G., ACAR C., TÜRKYILMAZ D., YİĞİT KAYA S., TUNALI S., et al.

Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi , cilt.29, sa.2, ss.65-69, 2015 (Hakemli Dergi)

16. The Effect of Fc gamma RIIIA Gene Polymorphism on the Treatment of Diffuse Large B-cell Non-Hodgkin Lymphoma: A Multicenter Prospective Observational Study

Buyukkurt N., ÖZCAN M. A., Ergene U., Payzin B., Tunah S., DEMİRKAN F., et al.

TURKISH JOURNAL OF HEMATOLOGY , cilt.32, sa.2, ss.152-157, 2015 (SCI-Expanded)

17. Hypoalbuminemia is a surrogate biomarker of poor prognosis in myelodysplastic syndrome even when adjusting for comorbidities

Sevindik O. G., Guc Z., Kahraman S., Solmaz S. M., Katgi A., Acar C., et al.

LEUKEMIA & LYMPHOMA , cilt.56, sa.9, ss.2552-2555, 2015 (SCI-Expanded)

18. IPSET-thrombosis better identifies thrombosis-free survival: A Turkish cohort

Sevindik O. G., Mersin S., Katgi A., TUNALI S., Solmaz S. M., Acar C., et al.

Clinical Lymphoma, Myeloma and Leukemia , cilt.15, sa.6, 2015 (SCI-Expanded)

19. Renal and Neurological Response with Eculizumab in a Patient with Transplant Associated Thrombotic Microangiopathy after Allogeneic Hematopoietic Progenitor Cell Transplantation

Sevindik O. G., ALACACIOĞLU İ., Katgi A., Solmaz S. M., Acar C., Piskin O., et al.

CASE REPORTS IN HEMATOLOGY , cilt.2015, 2015 (ESCI)

20. Nilotinib Results in Improved Rates of Molecular Response in Turkish Newly Diagnosed CML-CP Patients: A 24-Month Update

SAYDAM G., HAZNEDAROĞLU İ. C., KAYNAR L., Yavuz A., ALİ R., GÜVENÇ B., et al.

BLOOD , cilt.124, sa.21, 2014 (SCI-Expanded)

21. Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers

ALACACIOĞLU İ., Medeni S. S., ÖZSAN G. H., Payzin B., Sevindik O. G., Acar C., et al.

CHEMOTHERAPY , cilt.60, sa.4, ss.219-223, 2014 (SCI-Expanded)

22. Investigation of inherited thrombophilias in patients with pulmonary embolism

Turan O., ÜNDAR B., GÜNAY T., Akkoclu A.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.24, sa.2, ss.140-149, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Disseminated Fusarium Infection in an Acute Lymphoblastic Leukemia (ALL) Patient after Allogeneic Bone Marrow Transplantation

Solmaz S. M., Sevindik O. G., Acar C., ALACACIOĞLU İ., Piskin O., ÖZSAN G. H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.3, ss.13-15, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

24. Management of IFI in Febrile Neutropenic Patients: A Case of Invasive Aspergillosis Treated with Liposomal Amphotericin B

Skvindik O. G., Solmaz S. M., Acar C., ALACACIOĞLU İ., Piskin O., ÖZSAN G. H., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.3, ss.16-17, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

25. Occurrence in a case of Philadelphia negative acute lymphoblastic leukemia following treatment for Ewing's sarcoma Ewing sarkom tedavisi sonrası gelişen Philadelphia negatif akut lenfoblastik lösemi olgusu

Katgi A., Kahraman S., Ataca P., Pişkin Ö., ÖZCAN M. A., ÖZSAN G. H., et al.

Marmara Medical Journal , cilt.25, sa.2, ss.100-102, 2012 (Scopus)

26. Ischemic stroke after recombinant factor VIIa treatment in acquired hemophilia A patient

Katgi A., Ataca P., Kahraman S., Piskin O., Ozcan M. A., DEMİRKAN F., et al.

BLOOD COAGULATION & FIBRINOLYSIS , cilt.23, sa.1, ss.69-70, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

27. Central retinal artery occlusion as the presenting sign of essential thrombocythemia

ARIKAN G., SAATCİ A. O., Kahraman S., Piskin O., MEN S., ÜNDAR B.

TURKISH JOURNAL OF HEMATOLOGY , cilt.28, sa.2, ss.146-148, 2011 (SCI-Expanded)

28. Prognostic significance of immunohistochemical classification of diffuse large B-cell lymphoma

ALACACIOĞLU İ., ÖZCAN M. A., ÖZKAL S., Piskin O., Turgut N., DEMİRKAN F., et al.

HEMATOLOGY , cilt.14, sa.2, ss.84-89, 2009 (SCI-Expanded)

29. Prognostic Factors and Scoring Systems in Chronic Myelomonocytic Leukemia: A Retrospective Analysis of 37 Patients

DEMİRKAN F., ALACACIOĞLU İ., Piskin O., ÖZSAN G. H., ÖZCAN M. A., ÜNDAR B.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.18, sa.4, ss.193-200, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

30. Clinical characteristics and treatment results of primary gastrointestinal lymphoma patients: Single center experience Primer gastrointestinal lenfoma hastalarinin klinik özellikleri ve tedavi sonuçlari: Tek merkez deneyimi

ALACACIOĞLU İ., ÖZCAN M. A., MERAL M., PİŞKİN Ö., DEMİRKAN F., Özsan G. H., et al.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.17, sa.3, ss.143-150, 2007 (Scopus)

31. Myelomatous effusion in plasma-cell leukemia: A case report

ALACACIOĞLU İ., ÖZCAN M., Pişkin Ö., DEMİRKAN F., ÖZSAN G. H., ÜNDAR B.

UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi , cilt.17, sa.3, ss.163-166, 2007 (SCI-Expanded)

32. Plasma thrombin activatable fibrinolysis inhibitor levels in Behcet's disease

ÖZCAN M. A., Akar S., ALACACIOĞLU İ., Pişkin Ö., YÜKSEL F., Gürler O., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.37, sa.5, ss.267-271, 2007 (SCI-Expanded, Scopus, TRDizin)

33. Synergistic effect of imatinib mesylate and fludarabine combination on Philadelphia chromosome-positive chronic myeloid leukemia cell lines

Pişkin Ö., Özcan M., Özsan G. H., Ateş H., Demirkan F., Alacacıoğlu İ., et al.

Turkish Journal of Hematology , cilt.24, sa.1, ss.23-27, 2007 (SCI-Expanded)

34. The effect of imatinib mesylate on the erythroid colony formation from patients with polycythemia vera in the presence of different cytokines

Pişkin Ö., Özsan G. H., Ateş H., Özcan M. A., Demirkan F., Alacacıoğlu İ., et al.

Turkish Journal of Hematology , cilt.23, sa.3, ss.136-141, 2006 (SCI-Expanded)

35. Platelet satellitism in a pregnant woman

ÖZCAN M. A., Pişkin Ö., ALACACIOĞLU İ., ÜNDAR B.

Turkish Journal of Hematology , cilt.23, sa.2, ss.119, 2006 (SCI-Expanded)

36. Plasma levels of thrombin activatable fibrinolysis inhibitor antigen in active and inactive inflammatory bowel disease

ÖZCAN M. A., AKARSU M., DEMİRKAN F., AKPINAR H., YÜKSEL F., ÖZSAN G. H., et al.

Turkish Journal of Hematology , cilt.23, sa.2, ss.94-99, 2006 (SCI-Expanded)

37. Chronic myeloid leukaemia associated with extreme thrombocytosis

ALACACIOĞLU İ., ÖZCAN M. A., Piskin O., DEMİRKAN F., ÖZSAN G. H., ÜNDAR B.

HAEMA , cilt.8, sa.4, ss.701-703, 2005 (Scopus)

38. Infarction of an accessory spleen secondary to splenic vein thrombosis in essential thrombocytosis

SEÇİL M., Akar S., GÜLCÜ A., Igci E., ÜNDAR B., Akkoc N.

CMIGExtra: Cases , cilt.28, sa.6, ss.55-58, 2004 (Scopus)

39. Refractory thrombocytopenia with multilineage dysplasia: A rare type of myelodysplastic syndrome

DEMİRKAN F., ÖZSAN G. H., ÖZCAN M. A., Vural F., ÖZTOP İ., Yüksel E., et al.

Turkish Journal of Haematology , cilt.20, sa.1, ss.25-30, 2003 (SCI-Expanded)

40. Spontaneous remission in acute leukemia: A report of two cases

ÖZSAN G. H., DEMİRKAN F., ÖZTOP İ., ÖZCAN M., Vural F., ÜNDAR B.

THOD - Turk Hematoloji-Onkoloji Dergisi , cilt.12, sa.2, ss.99-102, 2002 (Scopus)

41. Effect of sialic acid on platelet cryopreservation

Özsan G. H., Pişkin Ö., Demirkan F., Ateş H., Özcan M., Ündar B.

Turkish Journal of Haematology , cilt.18, sa.4, ss.251-257, 2001 (SCI-Expanded)

42. Plasma cell leukemia: A report of 5 cases and review of the literature

DEMİRKAN F., ÖZSAN G. H., ÖZCAN M., Vural F., Cabuk M., ÜNDAR B.

Turkish Journal of Haematology , cilt.18, sa.4, ss.275-279, 2001 (SCI-Expanded)

43. Unstable angina pektoriste C-reaktif protein, interleukin-6 ve aktive T lenfosit düzeyleri ve iskemi ile ilişkisi

KIRIMLI Ö., GÜNERİ S., ÜNDAR B., BADAK Ö., ASLAN Ö., AKDENİZ B., et al.

Türk Kardiyoloji Derneği Arşivi , cilt.29, sa.8, ss.476-480, 2001 (Hakemli Dergi)

44. Emergence of Philadelphia positive chronic myeloid leukemia in a patient with Philadelphia negative acute lymphoblastic leukemia

DEMİRKAN F., Oztop İ., Ozsan H., Undar B.

LEUKEMIA & LYMPHOMA , cilt.42, sa.1-2, ss.251-252, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma

45. Consistent loss of heterozygosity at 14q32 in lymphoid blast crisis of chronic myeloid leukemia

Sercan H. O., Sercan Z., Kizildag S., Undar B., Soydan S., Sakizli M.

LEUKEMIA & LYMPHOMA , cilt.39, sa.3-4, ss.385-390, 2000 (SCI-Expanded)

46. Hydroxyurea treatment for chronic myeloid leukemia during pregnancy

CELİLOĞLU M., ALTUNYURT S., Undar B.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA , cilt.79, sa.9, ss.803-804, 2000 (SCI-Expanded)

47. High lactoferrin levels in disseminated intravascular coagulation and its possible negative role in coagulation.

Ozsan H., Pehlivan M., Demirkan F., Undar B., SAYAN M., Cehreli C.

Thrombosis research , cilt.98, sa.1, ss.111-4, 2000 (SCI-Expanded)

48. The use of different prognostic systems applied to myelodysplastic syndromes: A retrospective analysis

DEMİRKAN F., ÇABUK M., ÖZSAN G. H., Pehlivan M., Yuksel E., ÖZTOP İ., et al.

Turkish Journal of Haematology , cilt.17, sa.3, ss.101-109, 2000 (SCI-Expanded)

49. Flow cytometric analysis of circadian changes in platelet activation using anti-GMP-140 monoclonal antibody

Undar B., Akkoc N., Alakavuklar M., Cehreli C., Undar L.

CHRONOBIOLOGY INTERNATIONAL , cilt.16, sa.3, ss.335-342, 1999 (SCI-Expanded)

50. Non-Hodgkin Lenfomada Dilde Aktinomikoz

PEHLİVAN M., YENİÇERİOĞLU Y., DEMİRKAN H. M. B., ÖZSAN G. H., DEMİRKAN F., ERDEN E., et al.

FLORA-INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI , cilt.3, sa.3, ss.200-203, 1998 (Hakemli Dergi)

51. Platelet activation during the early neonatal period

Irken G., Uysal K., Olgun N., Undar B., Akkoc N., ÖZKAN H., et al.

BIOLOGY OF THE NEONATE , cilt.73, sa.3, ss.166-171, 1998 (SCI-Expanded)

52. Early ticlopidine-induced hepatic dysfunction, dermatitis and irreversible aplastic anemia after coronary artery stenting [1]

Ceylan C., KIRIMLI Ö., AKARSU M., ÜNDAR B., GÜNERİ S.

American Journal of Hematology , cilt.59, sa.3, ss.260, 1998 (SCI-Expanded)

53. Platelet activation in congenital heart diseases

Olgun N., Uysal K., Irken G., Unal N., Undar B., Akkoc N., et al.

ACTA PAEDIATRICA JAPONICA , cilt.39, sa.5, ss.566-569, 1997 (SCI-Expanded)

54. Meme Kanseri Tedavisinde Adjuvan Kemoterapi Maliyetinin Araştırılması

DEMİRKAN H. M. B., YILMAZ A. U., ALAKAVUKLAR M., ÜNDAR B., DEMİRKAN F., ÖZSAN G. H., et al.

The Journal of Breast Health , cilt.3, sa.4, ss.158-164, 1996 (ESCI)

55. Türkiye'deki Serviks Kanseri Sıklığı Az Gelişmiş Ülkelerle Benzerlik Göstermekte midir?

CEYLAN C., YILMAZ A. U., ÖZSAN G. H., DEMİRKAN H. M. B., ALANYALI H., USLU T., et al.

Acta Oncologica Turcica , cilt.29, sa.1-2, ss.9-13, 1996 (Hakemli Dergi) Sürdürülebilir Kalkınma

56. Paraneoplastic cerebellar degeneration in association with Hodgkin's disease: A report of two cases

Cehreli C., Payzin B., Undar B., Yilmaz U., Alakavuklar M.

ACTA HAEMATOLOGICA , cilt.94, sa.4, ss.210-213, 1995 (SCI-Expanded)

57. Lactic acidosis complicating disseminated non-Hodgkin’s lymphoma

ÜNDAR B., ÇEHRELİ C., DEMİRKAN H. M. B., OKTAY G.

TURKISH JOURNAL OF CANCER , cilt.24, sa.4, ss.211-215, 1994 (Hakemli Dergi)

58. Coexistence of chronic neutrophilic leukemia with light chain myeloma

Cehreli C., ÜNDAR B., Akkoc N., Onvural B., ALTUNGÖZ O.

Acta Haematologica , cilt.91, sa.1, ss.32-34, 1994 (SCI-Expanded)

59. ONCOGENOUS OSTEOMALACIA - REPORT OF A CASE

CEHRELI C., ALAKAVUKLAR M., CAVDAR C., BASDEMIR G., UNDAR B., AKKOC N., et al.

ACTA ONCOLOGICA , cilt.33, sa.8, ss.975-976, 1994 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 22

1. THE CORRELATION BETWEEN INTERIM IMAGING RESULTSAND DISEASE PROGNOSIS OF PATİENTS WİTH HODGKINAND DIFFUSE LARGE B CELL LYMPHOMA: SINGLE CENTEREXPERIENCE

erdoğan ç., SEYHANLI a., ALACACIOĞLU İ., PİŞKİN Ö., DEMİRKAN F., ÖZCAN M. A., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 Mayıs 2019, cilt.36, (Tam Metin Bildiri)

2. RETROSPECTIVE EVALUATION OF IMMUNOMUDULATORYAGENTS RESPONSE AND SIDE EFFECTS IN RELAPSEDREFRACTOY MYELOMA PATIENTS: REAL LIFE EXPERIENCE

erdoğan ç., SEYHANLI a., ALACACIOĞLU İ., PİŞKİN Ö., DEMİRKAN F., ÖZCAN M. A., et al.

7th International Congress on Leukemia Lymphoma Myeloma, 2 - 04 Mayıs 2019, cilt.36, (Tam Metin Bildiri)

16. IS BERLIN FRANKFURT MUNSTER BFM REGIMEN FEASIBLE FOR TREATMENT OF ADULT ACUTE LYMPHOBLASTIC LEUKEMIA RETROSPECTIVE ANALYSIS OF OUTCOME OF ADULT ALL TREATED WITH BFM AND HPER CVAD PROTOCOLS

ALACACIOĞLU İ., SOLMAZ Ş., ÖZSAN G. H., PAYZIN B., ACAR C., KATGI A., et al.

EHA CONGRESS, 10 - 13 Haziran 2015, cilt.100, ss.637-638, (Özet Bildiri)

17. Multiple myelomda bortezomib yanıtına T regülatuar hücrelerin etkisinin ex vivo sorgulanması

ERÇETİN A. P., ÖZCAN M. A., AKTAŞ S., YÜKSEL F., SOLMAZ MEDENİ Ş., SEVİNDİK Ö. G., et al.

2. Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Kayseri, Türkiye, 17 - 19 Nisan 2015, ss.79

18. Does reinfusion of stem cell products in multiple days affect engraftment

ALACACIOĞLU İ., TÜRKYILMAZ D., SOLMAZ Ş., ACAR C., SEVİNDİK Ö. G., PİŞKİN Ö., et al.

EBMT CONGRESS, 22 - 24 Nisan 2015, cilt.50, ss.343, (Özet Bildiri)

19. Otolog periferik kök hücre destekli yüksek doz kemoterapi verilen Multiple Myelom hastalarında gelişen nötropenik ateş

KAHRAMAN S., ÜNAL S., ALP ÇAVUŞ S., BÜYÜKKURT N., ÖZSAN G. H., ÖZCAN M. A., et al.

35. Ulusal Hematoloji Kongresi, Antalya, Türkiye, 7 - 10 Ekim 2009

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

259

H-İndeks (WoS)

Atıf (Scopus)

335

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Sobiad)

H-İndeks (Sobiad)

Atıf (Diğer Toplam)

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Sobiad)

H-İndeks (Sobiad)

Atıf (Diğer Toplam)

Tez Danışmanlığı

Açık Erişim